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Abstract: Studies have shown that following exposure to particulate matter, the ultrafine 
fraction (< 100 nm) may deposit along the respiratory tract down to the alveolar region. To 
assess the effects of nanoparticles in the lungs, it is essential to address the question of their 
biophysicochemical interaction with the different pulmonary environments, including the lung 
lining fluids and the epithelia. Here we examine one of these interactive scenarios and study the 
role of supported lipid bilayers (SLB) on the fate of 40 nm fluorescent silica particles towards 
living cells. We first study the particle phase behavior in presence of Curosurf®, a pulmonary 
surfactant substitute used in replacement therapies. It is found that Curosurf® vesicles interact 
strongly with the nanoparticles, but do not spontaneously form SLBs. To achieve this goal, we 
use sonication to reshape the vesicular membranes and induce the lipid fusion around the 
particles. Centrifugal sedimentation and electron microscopy are carried out to determine the 
optimum coating conditions and layer thickness. We then explore the impact of surfactant SLBs 
on the cytotoxic potential and interactions towards a malignant epithelial cell line. All in vitro 
assays indicate that SLBs mitigate the particle toxicity and internalization rates. In the 
cytoplasm, the particle localization is also strongly coating dependent. It is concluded that SLBs 
profoundly affect cellular interactions and functions in vitro and could represent an alternative 
strategy for particle coating. The current data also shed some light on potential mechanisms 
pertaining to the particle or pathogen transport through the air-blood barrier.  
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I – Introduction  
Airborne materials released by industrial activities are responsible for major heart and lung 
diseases, affecting an increasing number of humans in both developed and developing countries. 
Studies have shown that in polluted areas particulate matter can induce various adverse health 
effects such as premature mortality, asthma, allergic sensitization, and lung cancer.1-3 In the 
lungs, it has been found that particles are able to deposit all along the respiratory tract. To 
evaluate the effects of airways exposure to nanoparticles, it is thus essential to address the 
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question of their biophysicochemical interaction within the different pulmonary environments, 
from lung lining fluids to epithelia and tissues. 
 
The human respiratory system is composed of channels and ducts where air passes through the 
airways to reach the pulmonary alveoli during breathing. In the respiratory zone, alveoli provide 
a large area that favors the transfer of oxygen into the bloodstream and that of carbon dioxide 
from the bloodstream out of the lungs. With an average size of 200 µm, alveoli are made of thin-
walled parenchymal cells (0.5 µm) that are in direct contact with capillaries of the circulatory 
system.2 The air-wall interfaces are covered with pulmonary surfactant, which is essential for the 
lung physiology and also represents the first barrier against pathogens and harmful particles. 
Depending on their physico-chemical features nanoparticles can eventually cross the alveolar 
spaces and reach the bloodstream.1,2,4 Despite continuous efforts, the mechanisms of particles 
crossing the air-blood barrier are not yet known.  
 
In the search for appropriate systems to assess interactions with nanomaterials, different 
strategies have been pursued. Some studies focus on endogenous surfactant that is isolated from 
porcine broncho-alveolar lavage fluid.2,4-10 In such cases, the phospholipid dispersion contains 
the four main proteins SP-A, SP-B, SP-C and SP-D associated with pulmonary surfactant and 
their relative proportions are close to those in vivo. A second approach takes advantage from 
existing exogenous surfactants administered to premature infants of less than 32 weeks.9,11-21 
These surfactant formulations are of porcine (Curosurf®, Survanta®) or bovine (Alveofact®) 
origin and are part of efficient surfactant replacement therapies. Because they possess both SP-B 
and SP-C hydrophobic proteins, these substitutes are considered as reliable surfactant models. 
Finally, bilayers made from synthetic phospholipids are also used to mimic the physico-chemical 
interactions with particles.6,7,16,22-35 These dispersions usually consist of one or two types of 
lipids and do not contain any of the above-cited proteins. Particle interaction studies with 
pulmonary surfactants have shown a wide range of behaviors, including the formation of 
aggregates, decorated vesicles, supported lipid bilayers or of particles internalized inside the 
membrane.27,36-38 Working with Curosurf® at physiological concentration, Schleh et al. was one 
of the first to study the effect of nano- and microparticles on the structural and interfacial 
properties of the lung fluid.17 The authors found that bare titanium dioxides strongly associate 
with surfactant lipid membranes and modify their surface tension and layered structures. At non-
physiological concentrations, several studies reported the formation of large aggregates (> 1 µm) 
or more generally an amelioration of particle stability in presence of surfactant.16,20,39  
 
Here we focus on supported lipid bilayers (SLBs) deposited on nanoparticles. In real-life 
situations, particles crossing the air-liquid interface in the alveolar spaces may indeed be covered 
with SLBs.2,5 In this context, we aim at providing new understanding on the role of biomolecular 
films at nano-interfaces and their impact in vitro. Supported lipid bilayers were originally 
produced on planar surfaces using Langmuir-Blodgett/Langmuir-Schaefer deposition techniques, 
or by vesicle fusion. The mechanism of SLB formation on flat substrates is now well understood 
and results from a balance between hydration, Van der Waals and electrostatic dispersion 
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forces.40,41 On highly curved interfaces such as exhibited by nanoparticles however there has 
been less research.42 To make SLB-coated particles, several routes were explored and the lipid 
deposition was mediated using different approaches including liposomal fusion, solvent 
exchange, ionic strength variation or sonication.36,42 In recent years, SLBs have been obtained in 
combination with metal oxide,25,27,29,32,34,35 noble metal particles37 and with polymeric 
nanogels.13,14 However with a few exceptions,12,14 the SLB deposition on highly curved surfaces 
was obtained mainly using zwitterionic lipids of synthetic origin, and not with biological lipid 
mixtures.27,42 
 
In this work we propose a simple method to coat 40 nm model fluorescent silica nanoparticles 
with a supported bilayer, the bilayer being that of the exogenous surfactant Curosurf®. To our 
knowledge, it is the first time that SLBs from surfactant substitute are achieved on particles 
below 100 nm. Silica particles are chosen because their physico-chemical features (size, surface 
charge, optical properties) can be accurately tuned by synthesis. For imaging and visualization 
purposes, the particles were made fluorescent by incorporating rhodamine molecules in the silica 
structure. To enhance the particle-vesicle adhesion energy and favor SLB formation via 
Coulombic forces,43,44 the particles are coated with high-density amine groups. At first we 
examine the particle-vesicle phase behavior as a function of concentration and temperature. Such 
an approach provides critical information on the colloidal interactions and assembled structures. 
It is shown that the nanoparticle-vesicle association is mainly driven by electrostatics and leads 
to large (> 1 µm) aggregates. The aggregates are found to be stable over time and the membranes 
do not reverse spontaneously into SLBs. To produce SLBs, we use sonication to reshape the 
vesicles and induce the lipid fusion around the particles. The vesicle-to-particle specific surface 
is optimized to have all silica particles coated with a lipid bilayer. We also address the question 
whether SLBs affect the particle interaction and uptake towards alveolar epithelial cells, yielding 
a positive response: SLB-coated particles exhibit a 20 – 50 times lower internalization compared 
to bare particles. We finally propose a mechanistic scenario to explain the reduction of particle 
toxicity and uptake, and suggest that in case of SLB formation, pulmonary surfactant tends to 
alleviate the negative impact of nanomaterials in alveolar spaces.  
 
 
II – Results and discussion 
II.1 – Nano supported lipid bilayer formulation 
Figs. 1a and 1b display representative cryo-TEM images of Curosurf® diluted at 5 g L-1. Images 
show that the phospholipids self-assemble locally into a bilayer structure of thickness 𝛿𝛿 = 4.36 ± 
0.39 nm (Supporting Information S1). When observed on a larger scale, the bilayers are found to 
close on themselves and form unilamellar and multivesicular vesicles. Multivesicular vesicles 
describe large compartments encapsulating one or several smaller vesicles.45 The vesicle size 
distribution derived from cryo-TEM extends from 50 to 1000 nm with a median value of 230 nm 
and a dispersity of 0.55 (Fig. 1c). The phospholipid structures observed for Curosurf® (Figs. 1a-
b and S2) are similar to those reported in the literature using cryo- and freeze-fracture electron 
microscopy.10,14,46,47 They are also comparable to those of endogenous surfactant obtained from 
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bronchoalveolar lavages.6 Fig. 1d shows a cryo-TEM image of the fluorescent silica synthesized 
by the Stöber technique. The particles are nearly spherical and characterized by a diameter of 
41.2 nm and a dispersity of 0.11 (Fig. 1e). A particle identity card displaying UV-Vis 
spectrometry, fluorimetry and light scattering data is provided in Supporting Information (S3). 
Concerning the surface charges, the particles are positive at pH 6 and below (zeta potential 𝜁𝜁 = + 
47 mV) with a charge density of +0.62e nm-2 and the vesicles are negative (𝜁𝜁 = – 55 mV).16,48 It 
is thus anticipated that vesicles and particles will interact strongly upon mixing.49,50  
 
 
 
Figure 1: Cryo-TEM images of Curosurf® (a,b) and of rhodamine-loaded fluorescent silica 
nanoparticles (d). c,e) Size distributions of vesicles and nanoparticles, respectively. For the 
vesicles, the size of each of the enclosed structures have been included into the full statistical 
analysis. The distribution is well accounted for by a log-normal function of median 230 nm and 
dispersity 0.55. For the particles, the median value is 41.2 nm and the dispersity 0.11. Extra 
Curosurf® illustrations are provided in S2.  
 
 
Mixed silica-surfactant dispersions were prepared at different concentration 𝑐𝑐 and surface ratio 
𝑋𝑋!, where 𝑋𝑋! denotes the ratio between the specific surface associated with the vesicles and that 
associated with the particles. With these notations, 𝑋𝑋! = 0 corresponds to a nanoparticle solution 
and 𝑋𝑋! = ∞ to a vesicular dispersion. Detailed calculations for 𝑋𝑋! are provided in the 
Supplementary Section S4. In a first attempt, a protocol described for synthetic lipids was 
reproduced using Curosurf®.29 The fluorescent silica particles were mixed with vesicles at pH 6 
and concentration 0.1 g L-1 with a large excess of membranes (𝑋𝑋! = 15). The choice of this pH 
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was imposed by the particle and vesicle physico-chemical properties (both are of oppositely 
charges and stable) and by the fact that it corresponds to the mildly acid conditions encountered 
in alveolar spaces.51,52 The mixed dispersion was studied over 24 h by light scattering, and 
revealed the formation of stable micron-sized aggregates. In a second attempt silica-surfactant 
mixtures were prepared over a wide range of surface ratios (𝑋𝑋! = 10
-4 to 104) following the 
Continuous Variation Method developed by us to study multicomponent systems.48,50,53 The 
screening of the phase diagram led to a marked scattering peak centered around 𝑋𝑋! = 2.6, 
indicating again the formation of mixed silica-vesicle aggregates over a broad range of 
conditions (S5).48 The results were similar for lipids in the gel or in the fluid membrane phase, 
which transition was determined by differential scanning calorimetry at 29.5 °C (Supplementary 
Information S6). To check whether the aggregate formation is specific to Curosurf®, additional 
experiments were performed using a protein-free surfactant constituted from 
dipalmitoylphosphatidylcholine (DPPC) and from two other lipids.16 Details about the lipids and 
their formulation are provided in the Materials and Methods section. The lipid dispersion was 
extruded through a 100 nm pore polycarbonate membrane, resulting in a highly uniform 
population of negatively charged vesicles (𝜁𝜁 = - 30 mV). Supplementary Information S7 
illustrates the static and dynamic light scattering for silica-vesicle mixed dispersions. At the two 
temperatures investigated (T = 25 °C and 37 °C) it was found that with synthetic lipids sub-
micron aggregates formed upon mixing and that the aggregate formation is not specific to the 
biologically relevant Curosurf® membranes. In conclusion, we show here that mixing positive 
fluorescent silica and negative Curosurf® vesicles does not lead to the spontaneous formation of 
supported lipid bilayers, but rather to uncontrolled electrostatics-driven aggregation.14 The 
discrepancy with the literature could come from the nature of the phospholipids and their 
interaction with silica surface groups. Most studies showing a membrane fusion on silica nano- 
and microparticles were performed using zwitterionic lipids of synthetic origin.31,32,36,42 
 
Sonication is a well-known technique to improve particle dispersability. For lipid membranes, 
sonication helps reshaping the lamellarity through the disruption and reformation of the 
assembled structures.54 Fig. 2a illustrates schematically the individual structures, the solid 
fluorescent silica particles at 𝑋𝑋! = 0 and the multivesicular vesicles at 𝑋𝑋! = ∞. Fig. 2b shows the 
hydrodynamic diameter of a 1 g L-1 Curosurf® dispersion (𝑋𝑋! = ∞) as a function of the 
sonication time. 𝐷𝐷! decreases rapidly and stabilizes around 72 nm (polydispersity index pdi 
0.34) after 20 minutes. Sonication performed on a mixed surfactant sample (𝑋𝑋! = 2.6) displays a 
similar behavior, the diameter reaching a value of 84 nm (pdi 0.31) at steady state. These 
decreases are in both cases accompanied with a strong reduction in the sample turbidity. 
Sonication was then carried out for 90 minutes at different 𝑋𝑋! and the solutions were investigated 
via light scattering and zetametry. Figs. 2c and 2d show the 𝐷𝐷!(𝑋𝑋!) and 𝜁𝜁(𝑋𝑋!)-dependencies for 
the sonicated dispersions. It is found that above a surface coverage of 2, both quantities exhibit 
stationary values. Similar results in DI-water and in cell culture medium (DMEM) confirm the 
robustness in the hybrid structures. Besides, the zeta potential decreases from + 47 mV for the 
silica particles, passes through zero at 𝑋𝑋!  = 1 and stabilizes at -30 mV above. The charge reversal 
observed here, together with a hydrodynamic diameter slightly larger than that of the bare silica 
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suggests that for 𝑋𝑋! ≥ 2 the particles are coated with a supported lipid bilayer. The fact that the 
optimum ratio was not 𝑋𝑋! = 1 could be due to the assumptions made to evaluate the particle and 
vesicle specific surfaces (S4).22 To demonstrate the presence of a double layer at the particle 
surface and measure its thickness, centrifugal sedimentation (DCS), transmission and cryo-
transmission electron microscopy experiments were conducted.  
 
 
 
Figure 2: a) Schematic representation of rhodamine-loaded fluorescent silica nanoparticles and 
of Curosurf® vesicles. The particles at pH 6 and below are positive (𝜁𝜁 = + 47 mV) and the 
vesicles are negative (𝜁𝜁 = – 55 mV). b) Hydrodynamic diameter 𝐷𝐷! versus sonication time for 
Curosurf® (𝑋𝑋! = ∞) and Curosurf® mixed with fluorescent silica nanoparticles (𝑋𝑋! = 2.6) at 1 g 
L-1. c and d) Hydrodynamic diameter 𝐷𝐷! and zeta potential 𝜁𝜁 as a function of the surface ratio 
𝑋𝑋! in DI-water and in DMEM cell culture medium. 
 
 
II.2 – Supported bilayer thickness determination 
Differential Centrifugal Sedimentation 
DCS was performed on 1 g L-1 sonicated dispersions at various surface ratios 𝑋𝑋! = 0, 1.3, 1.5, 
1.7, 2 and 5. Fig. 3a displays the absorbance measured as the particles are passing through the 
beam detector and plotted as a function of particle size. In the current configuration the 
dispersion is injected from the disk center and the sedimentation occurs to the outer range. As a 
result, mulivesicular vesicles alone cannot be detected, their density being lower than that of the 
sucrose gradient (1.064 g cm-3). For bare silica, the absorbance exhibits a peak centered at 45.0 
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nm. In presence of surfactant a peak is also observed but its position is shifted to lower values 
(43.3 nm). As shown in the inset, the data for 𝑋𝑋! = 1.3 – 5 are well superimposed near to the 
maximum. In the range 60 – 100 nm, the absorbance exhibits an additional contribution (arrow). 
This contribution has the form of a shoulder and results from particle-vesicle aggregates formed 
through electrostatic interaction, as discussed in the previous section. The DCS data 
superimposition suggests that 𝑋𝑋! = 2 leads to a complete particle coverage whilst limiting the 
excess of surfactant.  
 
 
 
Figure 3: a) DCS absorbance for 1 g L-1 sonicated fluorescent silica-surfactant dispersions at 
various surface ratios 𝑋𝑋! = 0, 1.3, 1.5, 1.7, 2 and 5. b) Corresponding number distributions 
calculated within the single adsorbed bilayer model. Inset in b): Representation of a rhodamine-
loaded silica particle coated with a single supported bilayer.  
  
 
The shift towards smaller diameter found with Curosurf® (45.0 nm versus 43.3 nm for the 
absorbance and 43.6 nm versus 40.8 nm for the size distribution) comes from the fact that the 
density entered in the DCS software is that of silica (𝜌𝜌 = 1.9 g cm-3), the one corresponding to 
actual silica-vesicle structures being unknown. In practice, the mass density indicated leads to an 
incorrect relationship between the sedimentation time and the size. Similar results were obtained 
by Krpetic et al. with gold nanoparticles and poly(ethylene glycol) coatings.55 In Supporting 
Information S8, the Stokes equation relating the sedimentation time 𝑡𝑡, the particle size 𝐷𝐷 and 
density 𝜌𝜌, 𝜌𝜌 − 𝜌𝜌! 𝐷𝐷!𝑡𝑡 = 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝜌𝜌 was evaluated assuming that the particles were coated with a 
single lipid bilayer of mass density 𝜌𝜌!"# = 0.9 g cm
-3.56,57 Solving the Stokes equation gives a 
total diameter of 47.2 nm and a layer thickness of 1.8 nm, which is smaller than the value 
obtained by cryo-TEM (S1). Fig. 3b displays the number distribution retrieved from the 
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absorbance data at various 𝑋𝑋! and corrected from the previous adjustment. In conclusion, DCS is 
an accurate technique for retrieving both particle size and particle distribution, however in cases 
of complex colloids a structural model is required a priori and the determination is only 
approximate.  
 
Transmission electron microscopy (TEM) 
For TEM experiments, 3 µL of a 𝑋𝑋! = 2 and 𝑐𝑐 = 0.05 g L
-1 silica-surfactant dispersion were 
deposited on a copper grid for 10 min followed by a subsequent addition of uranyl acetate. This 
compound provides a dark staining of the phospholipid heads due to the high affinity of uranium 
oxycation to carboxyl groups. Figs. 4a-c displayed images of the fluorescent silica particles at 
different scales. The particles are found to be non-aggregated and surrounded with a white coat 
that is identified as a supported lipid bilayer (blue arrows).16,47,58,59 A size analysis performed on 
𝑛𝑛 = 200 leads to the distributions in Fig. 4d. Mean diameters are 41.1 ± 4.6 nm and 56.7 ± 7.2 
nm for the bare and SLB-coated particles, resulting in a thickness 𝛿𝛿!"# of 7.2 nm. This value 
exceeds the bilayer thickness found for phospholipids and for Curosurf®.60 This discrepancy is 
attributed to the sample dehydration that leads to irregular contours and increases uncertainty in 
the SLB thickness determination.29,47 
 
 
 
Figure 4: a – c) TEM images of SLB-coated particles. The particles were prepared at 1 g L-1 as 
in Figs. 2 and 3 and diluted down to 0.05 g L-1 for observation. The supported lipid bilayer 
appears as a bright layer thanks to uranyl acetate staining. The bars are 300, 100 and 40 nm 
respectively. d) Size distributions determined from TEM for bare (red circles) and SLB-coated 
fluorescent (blue squares) silica. As indicated in the text and in Table I, the bilayer thickness was 
estimated at 7.2 nm.  
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Cryo-transmission electron microscopy 
Fig. 5a shows an overview of a sonicated silica–surfactant dispersion prepared at the surface 
ratio 𝑋𝑋! = 2 (𝑐𝑐 = 0.5 g L
-1). The image displays a large number of non-aggregated particles 
coexisting with few vesicles. A statistical analysis (𝑛𝑛 = 800) reveals that less than 5% are indeed 
vesicles and that their sizes are around 100 nm. Figs. 5b – 5d exhibit close-up views of the 
particles, which present a thin and bright layer of thickness 5.2 ± 0.6 nm at the periphery. These 
cryo-TEM images, together with others in Supporting Information S9 indicate that every 
detected particle appear to be decorated with a surfactant outer shell. They also confirm the DCS 
outcome stating that particle and vesicle specific surfaces should be equivalent around 𝑋𝑋! = 2. 
The SLB-coated particles observed by cryo-TEM are similar to those reported with phospholipid 
formulations.25,27,29,32,33 and with Curosurf®.13,14 Table I sums up the different results obtained 
from light scattering, DCS, TEM and cryo-TEM. Cryo-TEM yields a value that is the closest 
from that of the membrane, 𝛿𝛿 = 4.36 ± 0.39 nm (S1).  
 
 
 
 
Figure 5: a) Cryo-TEM image of a sonicated fluorescent silica–Curosurf® dispersion (𝑋𝑋! = 2). 
The particles were prepared at 1 g L-1 as in Figs. 2-4 and diluted down to 0.5 g L-1 for cryo-TEM 
observation. The blue and green arrows are pointing to surfactant vesicles and ice crystals 
respectively. The bar is 200 nm. b – d) Close-up views of fluorescent silica nanoparticles coated 
with a supported lipid bilayer at different magnifications (bars are 40 nm in b and c and 20 nm 
in d). e) Schematic representation of a SLB coat. 
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   DLS	   DCS	   TEM	   Cryo-­‐TEM	  
NP	  diameter	  (nm)	   60	   43.6	   41.1	   41.2	  
SLB-­‐coated	  silica	  
diameter	  (nm)	  
84	   47.2	   55.6	   51.6	  
	   	   	   	   	  𝛿𝛿!"#	  (nm)	   12	   1.8	   7.2	   5.2	  
	   	   	   	   	   
Table I: Fluorescent silica nanoparticle diameter with and without supported lipid bilayer 
determined by dynamic light scattering (DLS), differential centrifugal sedimentation (DCS), 
transmission electron microscopy (TEM) and cryogenic transmission electron microscopy (cryo-
TEM). The SLB thickness 𝛿𝛿!"# in the last line should be compared to the Curosurf® membrane 
thickness 𝛿𝛿 = 4.36 ± 0.39 nm.  
 
 
The colloidal stability of the coated particles was investigated over time and in different 
solvents. Fig. S10 in Supporting Information shows the time dependence of the hydrodynamic 
diameter and zeta potential in DI-water over 21 days and in DMEM culture medium with serum 
over one week. The size and charge were found stationary over the measuring periods, indicating 
that the supported bilayer remains firmly adsorbed at the particle surface, and that the coating 
insures long-term electrostatic as well as steric stability. To assess potential interactions with the 
surfactant vesicles, the Continuous Variation Method was applied.16,53 Fig. S11 displays the 
scattered intensity as a function of mixing ratio 𝑋𝑋 between 10-3 and 103. The scattering data were 
found to vary continuously from one stock solution to the other, showing indeed a quite different 
behavior than that of bare aminated silica (S5). In this case, the intensity was well accounted for 
by the non-interacting model, demonstrating that coated particles and vesicles do not mutually 
interact. In conclusion, we have shown that SLBs can be prepared on aminated silica using a 
surfactant substitute. Although particles and vesicles interact strongly via electrostatic attraction, 
SLBs do not form spontaneously upon mixing and need to be assisted by sonication. The SLB-
coated fluorescent silica are stable over time and can be used as such for in vitro studies.  
 
 
II.3 – Role of the SLB towards toxicity and internalization rates 
Toxicity assays 
We hereafter illustrate the effects of SLB coating on the toxicity and on the cell internalization in 
vitro. The cytotoxicity of the bare aminated fluorescent silica and surfactant formulations was 
assessed using A549 lung epithelial carcinoma cells combined with the WST-1 assay. WST-1 
was performed at increasing silica doses from 0.2 to 1000 µg mL-1 in serum free medium. Figs. 6 
a-c display the percentage of viable cells after a 24 h treatment with bare and SLB-coated silica 
as well as with Curosurf® alone. For bare particles, the viability exhibits a 50% increase at low 
dose, remains stationary until 100 µg mL-1 and decreases above, indicating a marked toxicity. 
This increase of viability at low concentration is typical of a hormesis effect related to cell 
adaptation.61 Studies have shown that particles with positive surface charges are more harmful 
than neutral or negative ones, as they are susceptible to cling to the plasma membrane via 
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electrostatic interactions and modify locally its integrity. Besides, the effect might be here 
amplified by the presence of amine groups that are known to induce membrane perforation.62 In 
contrast, exposing the A549 cells to surfactant and to SLB-coated fluorescent silica did not cause 
any significant reduction in cell viability. Fig. 6b and 6c display rather uniform cellular 
responses with a viability remaining around 100%. 
 
 
 
Figure 6: Cell viability of adenocarcinomic human alveolar epithelial A549 cells treated with 
bare aminated fluorescent silica (a), Curosurf® (b) and with SLB-coated particles (c). In c) the 
lower scale is that of the particles and the upper scale that of Curosurf®. Mixed nanoparticle-
vesicle dispersions in c) were prepared at 𝑋𝑋! = 2 and sonicated 90 min. Viability data are means 
± standards deviations (𝑛𝑛 = 3) and analyzed using one-way ANOVA and Dunnett’s tests with p 
= 0.0332, 0.0021, 0.002 and 0.0001, corresponding to one to four stars respectively. 
 
 
Confocal microscopy and internalization rates 
For confocal microscopy, the A549 cells were incubated with the rhodamine-loaded fluorescent 
silica particles at 1 g L-1 for 4 and 24 h. Fig. 7A – 7B display the 4 h bright field (first row) 
and confocal (middle row) images acquired for bare and SLB-coated nanoparticles. The blue and 
red fluorescence channels correspond to DAPI and rhodamine emissions, respectively. For 
uncoated fluorescent silica in Fig. 7A (panels a,b) the bright field image reveals the presence of 
intracellular vacuoles.63 These vacuoles are not present in cells incubated with SLB-coated 
particles (Fig. 7B). On fluorescence images, the particles are outlined as dots for both treatments, 
the dots being less numerous for coated particles. For the bare fluorescent silica, the dots also 
form large patches suggesting intracellular aggregation (S12). In Fig. 7A and 7B, the particles 
close to the nuclei are inside the cytoplasm as cells display red fluorescence at nucleus height 
levels, whereas those at the periphery are either internalized or adsorbed at the plasma 
membrane. Confocal images at 4 h and 24 h were globally similar. 
To provide quantitative figures, a fluorescence-based protocol was developed to evaluate the 
mass of internalized and adsorbed particles (Fig. 7C). Cells were incubated with the rhodamine-
loaded fluorescent silica particles at concentrations 5, 25, 50, 75 and 100 µg mL-1 for 4 h using 
96-well plates. A reference signal was obtained from bare silica dispersed in white DMEM. 
Varying linearly with concentration (continuous line in Fig. 7D), this signal allowed translating 
the fluorescence intensity into masses of internalized and adsorbed particles. Fig. 7D compares 
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the 4 h incubation data for bare aminated and SLB-coated fluorescent silica. In both assays, the 
experimental mass increases roughly linearly with the applied dose. However, bare silica levels 
are systematically above those with a SLB coating by a factor 20 to 50. To account for such 
behaviors, we assume that electrostatics is playing a crucial role. The SLB-coated particles being 
negatively charged and disperse (S9), they are able to diffuse rapidly and interact with the 
membrane by random collisions in single particle events. Bare aminated silica in contrast are 
positively charged and adsorb at the plasma membrane via charge complexation. As particles 
agglomerate in cell medium, mixed aggregates are susceptible to settle and enter in contact with 
the cell membranes. In conclusion, we have seen that supported lipid bilayers from pulmonary 
surfactant profoundly affect cellular interactions, probably due to a combination of charge and 
dispersability effects.  
 
 
 
 
Figure 7: A) Bright field (a,b), confocal microscopy (c,d) and merge (e,f) images of A549 
alveolar epithelial cells incubated with bare rhodamine-loaded fluorescent silica. In the bright 
field images, micron sized vacuoles are observed. The blue and red fluorescence channels 
correspond to DAPI and rhodamine emissions, respectively. The bars in (a,c,e) are 20 µm and in 
(b,d,f) 10 µm. B) Bright field (a-c), confocal microscopy (d-f) and merge (g-i) images of A549 
alveolar epithelial cells with fluorescent silica coated with a 5 nm thick Curosurf® supported 
lipid bilayer. The bars in (a,d,g) are 20 µm and in (b,c,e,f,h,i) 10 µm. Additional confocal 
images are shown in Supporting Information S12. C) Schematic representation of a A549 cell 
with adsorbed and internalized nanoparticles. D) Mass of internalized-adsorbed silica as a 
function of the dose for bare aminated and SLB-coated fluorescent silica nanoparticles. 
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II. 4 - Intracellular localization 
Here we determine the experimental conditions under which the fluorescent silica particles 
interact with epithelial cells and where they are located in the cytoplasm. The particle 
localization was investigated by TEM on 70 nm thick microtomed cell sections. The exposure 
conditions were 4 h and silica concentration of 1 g L-1. Figs. 8a – 8e display representative 
images of A549 cells incubated with bare particles. In Fig. 8a, an image of a cell suggests the 
presence of micrometer large intracellular vacuoles similar to those seen in optical microscopy. 
These vacuoles are the signature that the cytoplasm integrity was damaged and that cells are 
undergoing a cellular death process. On the same figure, nanoparticle aggregates are also visible 
beyond the cell limits (arrows).  
 
 
 
Figure 8: a-e) TEM images of A549 alveolar epithelial cells incubated with rhodamine-loaded 
fluorescent silica particles. The red arrows in a), c) and e) highlight the presence of 
nanoparticle aggregates. The orange arrows in d) and e) point out to examples of disrupted cell 
membrane. N, V and M denote nucleus, vacuole and mitochondria respectively. Bars are 3 µm in 
a), 500 nm in b) and 200 nm in c-e).  
 
 
Close-up views illustrated in Figs. 8b and 8c indicate that the large vacuoles are empty, 
confirming the absence of co-localization seen in confocal microscopy. Moreover, every 
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detected particle appears to be in the cytosol and not in membrane bound-compartments. In most 
cases, the particles are aggregated in clusters of a few units. In this assay, nanoparticles were 
found neither in the nucleus nor in mitochondria. Fig. 8d and 8e show examples of aggregates 
adsorbed at the outer lipid layer. In the first figure the membrane appears to be disrupted over 
100 nm after the passage of a group of 4 particles (arrow). In the second, the particles engulf into 
the cytosol without deforming the membrane. These findings differ from those found with 
anionic or neutral particles for which internalization occurs via endocytosis and formation of 
endosomal compartments.64-67 Pertaining to the entry mechanism, the results suggest an 
internalization process via membrane perforation, most likely induced by charge and amine 
group effects.62 
 
Fig. 9 displays TEM images of cells treated with SLB-coated fluorescent silica in the same 
conditions (see also Supporting Information S13). There are here substantial changes compared 
to Fig. 8. The TEM images do not show any vacuole and aggregate at the outer membrane or in 
surrounding fluid, and the whole cell seems to contain fewer particles (Fig. 9a). This outcome is 
confirmed in the lower panels (Figs. 9b-d), where magnified views reveal individual particles or 
small clusters located only in membrane-bound compartments.64,65,67 These compartments are 
identified as lysosomes, as their interiors have a electron dense lumen.68 A few endosomes were 
nevertheless observed in the TEM images. With the current spatial resolution, it is not possible 
to conclude whether the supported layers are still present, or if the lipids have fused with the 
outer cellular membrane. Further studies are necessary to conclude about this point. Particles 
were not found in the nucleus or associated with other intracellular organelles. These results are 
consistent with those obtained from toxicity and internalization rate discussed previously. They 
are also in line with recent in vitro data on 50 nm silica particles exposed to cells in the presence 
of serum.66 There, the protein corona ensured a weak cellular membrane adhesion and a low 
internalization efficiency, highlighting the role of biomolecular coating in the nanomaterial-cell 
interactions.  
 
 
III – Conclusion 
Previous studies suggest the potential formation of hybrid structures between the pulmonary 
surfactant lining the alveoli and inhaled particles. Here we examine one of these interaction 
scenarios and study the role of supporting lipid bilayers on the fate of fluorescently labeled silica 
nanoparticles towards a malignant epithelial cell line. For that we focus on Curosurf®, an 
exogenous surfactant administered to premature babies suffering from respiratory distress 
syndrome. In the context of the present study, Curosurf® offers many advantages: i) it possesses 
the membrane proteins SP-B and SP-C which are essential for the air-liquid interface 
structuration; ii) its physico-chemical properties are also well controlled by the manufacturer and 
experiments are reproducible from batch to batch; iii) it also exhibits excellent temporal stability, 
allowing to perform extensive characterization and interaction experiments.16 Using a 
combination of light scattering, zeta potential and cryo-TEM experiments, it is first shown that 
the Curosurf® is made of multivesicular vesicles of sizes in the range 100 nm - 5 µm. 
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Figure 9: TEM images of A549 alveolar epithelial cells incubated with SLB-coated fluorescent 
silica particles. The arrows are pointing out to nanoparticles enclosed in cellular compartments. 
The coated particle dispersion were prepared at 𝑋𝑋! = 2 according to the protocol described in 
Section II.1. Bars are 2 µm in a), 500 nm in b) and 100 nm in c-e). Additional TEM images are 
shown in Supporting Information S13. 
 
 
To enhance the particle-membrane adhesion energy, the particles were made positive so that they 
can interact with the negatively charged Curosurf® vesicles via Coulombic forces. In the current 
work, we establish the multi-component phase diagram of these 40 nm silica particles with the 
pulmonary surfactant model, Curosurf®. When mixed together, strong electrostatic interactions 
result and lead to the formation of micrometer large aggregates. To produce SLBs, we start from 
such aggregates and applied sonication. The fine-tuning of the silica and vesicle specific surfaces 
enables to determine an optimum nanoparticle-to-vesicle surface 𝑋𝑋!. Above 𝑋𝑋! = 2 all particles 
observed upon cryo-TEM are covered with a single supported bilayer. In the process the 
particles reverse their charges, from positive at low 𝑋𝑋! to negative above 𝑋𝑋! = 2. Instances of 
monolayers or multi-bilayers coating are not found using this approach. The SLB characteristics 
are obtained from a combination of different structural measurements, including centrifugal 
sedimentation, transmission and cryo-transmission electron microscopy. It is concluded that 
cryo-TEM provides the most accurate determination for the SLB thickness, 𝛿𝛿!"# = 5.2 ± 0.6 nm, 
Wednesday,	  September	  6,	  2017	  
	  
 
 
16 
in good agreement with that of Curosurf® membranes. The other techniques used either 
overestimate (like light scattering and TEM) or to underestimate (DCS) this thickness. Once 
formed, the SLB coated particles exhibit a robust stability in various solvents, a result that is 
ascribed to the strong local electrostatic interaction between the phospholipid head groups and 
the surface amines. To our knowledge, it is the first time that SLBs from surfactant substitute are 
achieved on particles below 100 nm.  
In a second part, we explored the impact of surfactant SLBs on the cytotoxic potential and 
interactions towards A549 lung epithelial carcinoma cells. In contrast to bare particles which 
elicit a marked toxicity, SLB-coated silica display a rather uniform cellular responses with a cell 
viability remaining around 100% up to the highest dose level. It is also shown that SLB-coated 
silica are 20 to 50 times less internalized compared to uncoated nanoparticles. In the cytoplasm, 
the particles localization is also strongly coating dependent. Bare particles are massively 
internalized and found freely dispersed in the cytosol, whereas particles with SLB are located 
exclusively in endosomes and lysosomes. In conclusion we show here that supported lipid 
bilayers made from pulmonary surfactant and deposited on nanoparticles durably affect cellular 
interactions and functions in vitro. The current data also shed some light on potential 
mechanisms pertaining to the particle transport through the air-blood barrier, and confirm that 
lung lining fluids represent an efficient barrier against pathogens and harmful particles. The 
deposition and the adsorption of biologically relevant membranes on curved interfaces should 
also open up new ways for functionalizing inorganic surfaces. 
 
 
IV – Materials and Methods 
IV.1 – Materials 
Surfactant substitutes 
Curosurf®, also called Poractant Alfa (Chiesi Pharmaceuticals, Parma, Italy) is porcine minced 
pulmonary surfactant extract.11 It is produced as a 80 g L-1 phospholipid and protein suspension 
containing among others phosphatidylcholine lipids, phosphatidylglycerol and the membrane 
proteins SP-B and SP-C.46 Curosurf® is indicated for the rescue treatment of Respiratory 
Distress Syndrome (RDS) in premature infants and is administered at a dose of 200 mg per 
kilogram. In the present study, Curosurf® is considered as a pulmonary surfactant model that 
offers substantial advantages: its formulation is well controled and its composition and internal 
structure are not susceptible to changes from one batch to another (in contrast for instance with 
endogenous surfactant). According to Chiesi, the pH of Curosurf® is adjusted with sodium 
bicarbonate to pH 6.2, which is close to the pH of the endogenous pulmonary surfactant.51,52 The 
actual pH measured on different batches was in fact comprised between 5.5 and 6.5.16 Curosurf® 
was kindly provided by Dr. Mostafa Mokhtari and his team from the neonatal service at Hospital 
Kremlin-Bicêtre, Val-de-Marne, France.  
For the protein-free surfactant studied with the Continuous Variation Method, we used a mixture 
of phospholipids made from dipalmitoylphosphatidylcholine (DPPC), L-α-Phosphatidyl-DL-
glycerol sodium salt from egg yolk lecithin (PG) and 2-Oleoyl-1-palmitoyl-sn-glycero-3-
phospho-rac-(1-glycerol) (POPG). The lipids were initially dissolved in methanol at 10, 10 and 
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20 g L-1 respectively and then mixed in proper amounts for a final weight concentration of 80% / 
10% / 10% of DPPC/PG/POPG. The solvent was evaporated under low pressure at 60 °C for 30 
minutes. The lipid film formed on the bottom of the flask was then rehydrated with the addition 
of Milli-Q water at 60 °C and agitated at atmospheric pressure for another 30 minutes. Milli-Q 
water was added again to finally obtain a solution at 1 g L-1.  
 
Fluorescent silica nanoparticles 
The positively charged silica particles were synthetized using the Stöber synthesis.69 Briefly, 
fluorescent silica seeds were prepared using rhodamine and silica precursors.70 In a second step a 
non-fluorescent silica shell was grown to increase the particle size. Functionalization by amine 
groups was then performed, resulting in a positively charged coating.71 Aminated silica were 
synthesized at 40 g L-1 and diluted with DI-water at pH 6. The particles were characterized by 
light scattering and transmission electron microscopy, yielding for the hydrodynamic diameter 
𝐷𝐷! = 60 nm and for the core diameter 41.2 nm. Fluorescence properties were characterized using 
a Cary Eclipse fluorimeter (Agilent), leading excitation and emission peaks at 572 nm and 590 
nm respectively. The identity card of the fluorescent silica particles, including data from UV-Vis 
spectrometry, fluorimetry and light scattering is provided in Supporting Information S3.  
 
Chemicals 
Phosphate buffer saline (PBS1X), trypsin–EDTA, DMEM GlutaMAXTM, DMEM without red 
phenol (called white DMEM in the following), fetal bovine serum (FBS) and penicillin-
streptomycin were purchased from Gibco, Life Technologies. 2-(4-iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulphophenyl)-2H-tetrazolium (WST-1) was bought from Roche 
Diagnostics, Basel, Switzerland. Water was deionized with a Millipore Milli-Q Water system. 
All the products were used without further purification. 
 
IV.2 – Experimental techniques 
Mixing and sonication protocols 
Mixed fluorescent silica and surfactant dispersions were characterized by the surface ratio 𝑋𝑋!, 
which denotes the specific surface of membranes associated to the vesicles divided by that 
developed by the particles. The nanoparticle stock solutions were prepared at 6 g L-1 and at pH 6 
in DI-water while the Curosurf® concentrations were adjusted to have the desired surface ratio. 
As already mentioned, the requirement on the pH was imposed by the particle and vesicle 
physico-chemical properties and by the fact that it corresponds to the mild acidic conditions 
encountered in alveolar spaces. Adjusting the pH of the stock solutions also ensures that no 
aggregation of nanoparticles occurs owing to the pH gap.72 Upon mixing, interactions between 
particles and vesicles occurred rapidly due to their opposite surface charges.48-50 Pertaining to the 
sonication, a sonicator bath (Bioblock Scientific, model 89202) working at the frequency of 35 
kHz and an applied power of 55 W was used. During sonication, the temperature was maintained 
between 30 °C and 40 °C. For light scattering and zeta potential experiments, silica-surfactant 
dispersions were diluted between 0.1 and 1 g L-1 in particles to reduce absorption. 
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Static and Dynamic Light scattering 
The scattered intensity 𝐼𝐼! and the hydrodynamic diameter 𝐷𝐷! were determined using a NanoZS 
Zetasizer (Malvern Instruments). The second-order autocorrelation function is analyzed using 
the cumulant and CONTIN algorithms to determine the average diffusion coefficient 𝐷𝐷!  of the 
scatterers. Hydrodynamic diameter is then calculated according to the Stokes-Einstein relation 
𝐷𝐷! = 𝑘𝑘!𝑇𝑇/3𝜋𝜋𝜋𝜋𝐷𝐷!  where 𝑘𝑘! is the Boltzmann constant, 𝑇𝑇 the temperature and 𝜂𝜂 the solvent 
viscosity. Measurements were performed in triplicate at 25 °C and 37 °C after an equilibration 
time of 120 s. 
 
Electrophoretic mobility and zeta potential 
Laser Doppler velocimetry using the phase analysis light scattering mode and detection at an 
angle of 16° was used to carry out the electrokinetic measurements of electrophoretic mobility 
and zeta potential with the Zetasizer Nano ZS equipment (Malvern Instruments, UK). Zeta 
potential was measured after a 120 s equilibration at 25 °C. 
 
Transmission electron microscopy (TEM and cryo-TEM) 
TEM imaging was performed with a Tecnai 12 operating at 80 kV equipped with a 1k×1k Keen 
View camera. A 3 µL drop of silica-surfactant dispersion (concentration 0.05 g L-1) was 
deposited on holey-carbon coated 300 mesh copper grids (Neyco). The sample was stained 
during 30 s with uranyl acetate at 0.5 wt. %. Uranyl acetate provides a dark labeling of the 
phospholipid heads due to the high affinity of the electron dense ion uranyl to carboxyl groups. 
Grids were let to dry at room temperature in the dark for 20 min. For cryo-TEM, few microliters 
of surfactant (concentration 5 g L-1 in DI-water) or silica–surfactant dispersions (concentration 
0.5 g L-1 in white DMEM) were deposited on a lacey carbon coated 200 mesh (Ted Pella Inc.). 
The drop was blotted with a filter paper using a FEI VitrobotTM freeze plunger. The grid was 
then quenched rapidly in liquid ethane to avoid crystallization and later cooled with liquid 
nitrogen. The membrane was then transferred into the vacuum column of a JEOL 1400 TEM 
microscope (120 kV) where it was maintained at liquid nitrogen temperature thanks to a cryo-
holder (Gatan). The magnification was comprised between 3000× and 40000×, and images were 
recorded with an 2k×2k Ultrascan camera (Gatan). TEM and cryo-TEM images were digitized 
and treated by the ImageJ software and plugins (http://rsbweb.nih.gov/ij/).  
 
Differential Centrifugal Sedimentation  
Particle size distributions were measured using a DCS disc centrifuge DC24000 UHR (CPS 
Instruments Inc.). Sucrose solutions at 8 and 24 wt. % were freshly prepared in DI-water, and 
mixed in order to have solutions at 22, 20, 18, 16, 14, 12 and 10 wt. %. 1.6 mL of solutions were 
filled successively in nine steps, from 24 to 8 wt. % into the disc rotating at a speed of 21000 
rpm. Calibration was performed using poly(vinyl chloride) particles (0.239 µm, Analytik Ltd.) as 
calibration standard before each measurement. As particles are centrifuged through the sucrose 
gradient, they pass through the detector beam and the absorbance increases. The absorbance 
versus time data is then translated into the size number distribution of the particles. For the 
mixed silica-surfactant samples, 100 µL of nanoparticles (concentration 1.5 g L-1) were injected 
Wednesday,	  September	  6,	  2017	  
	  
 
 
19 
into the disc centrifuge, and each sample was analyzed in triplicate to verify data reproducibility. 
The mean of these three results was calculated for further data analysis.  
 
Optical and confocal microscopy 
For confocal microscopy, samples were examined with an inverted wide-field microscope 
(Olympus IX81) equipped with a spinning disk module (Yokogawa CSU-X1), with an oil 
immersion objective (60×, NA 1.42) and a EMCCD camera (Andor iXon 897). Z-stacks of 
wide-field fluorescent images were acquired using a piezo at 0.2 µm increments. For the DAPI 
channel, 405 nm laser-line excitation and a 465 nm-centered emission filter were used. For the 
red channel, the excitation line was 488 nm and the emission filter was centered at 590 nm. 
Addition confocal experiments were made at the Plateforme ImagoSeine (Institute Jacques 
Monot, Paris, France) using a LSM 710 (Zeiss) microscope equipped with an oil immersion 40× 
objective.  
 
IV.3 – Cellular biology 
A549 epithelial cell culture 
Adenocarcinomic human alveolar epithelial cells A549 (ATCC reference CCL-185TM) were 
grown in T75-flasks in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. 
Exponentially growing cultures were maintained in a humidified atmosphere of 5% CO2 and 
95% air at 37 °C. When the cell confluence reached 80%, cell cultures were passaged using 
trypsin–EDTA. 
 
WST-1 Toxicity assay 
Cells were seeded in a 96-well plate at 20000 cells per well in white DMEM with serum. After 
24 h, cells were rinsed with PBS and incubated for another 24 h at 37 °C with 200 µL of a 
fluorescent silica dispersion (in white DMEM). Cells were rinsed with PBS and incubated for 30 
min with 100 µL of WST-1 per well (dilution 1:20 in white DMEM). The assay is based upon 
the reduction by cellular dehydrogenase of the achromatic tetrazolium salt WST-1 to the dark 
yellow colored soluble formazan. The generation of formazan was measured at 450 nm in a 
microplate reader (ELx808, Biotek Instruments, Winooski, United States) against a blank 
containing culture media and WST-1 and data were corrected from the absorbance at 630 nm. 
Positive controls were performed with hydrogen peroxide (H2O2) and the non-interference 
between nanoparticles, cells and WST-1 was assessed treating half of the cultures with Triton 
(2% in white DMEM, 15 min of incubation at 37 °C) according to Vietti et al..73 Data are 
represented as means ± standards deviations (𝑛𝑛 = 3) and are analyzed with the GraphPad Prims 7 
software using variance analysis (one-way ANOVA) followed by Dunnett’s test with p = 0.0332, 
0.0021, 0.002 and 0.0001 (one to four stars respectively). 
 
Cell preparation for confocal microscopy 
A549 epithelial cells were seeded on coverslips in 6-well chamber at 200000 cells per well in 
white DMEM with serum. After 48 h, cells were incubated 4 h at 37 °C with fluorescent silica 
particles (1 mL at 1 g L-1 in white DMEM), then rinsed with PBS and finally fixed during 20 min 
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at 37°C with 700 µL of a 4% paraformaldehyde solution (J61899, Alfa Aesar) in PBS. After 
rinsing, the nuclei were fluorescently stained with DAPI (Aldrich) by incubation for 20 min at 
room temperature in dark conditions (dilution 1:1000 in PBS). The cells were thereafter washed 
three times with PBS to remove the dye in excess. The coverslips were then taken out of the 
wells and mounted onto a Gene Frame® adhesive system.  
 
Quantitative determination of adsorption/internalization efficiency 
A549 epithelial cells were seeded in a 96-well plate at 10000 cells per well in white DMEM with 
serum. After 48 h, the cells were rinsed with PBS and incubated for 4 h at 37 °C with fluorescent 
silica nanoparticles, with a dose from 5 to 100 µg mL-1. After rinsing with white DMEM, 
fluorescence was recorded using a Flexstation 3 (Molecular Device, 𝜆𝜆!" = 533 nm, 𝜆𝜆!" = 590 
nm, cut-off 570 nm). The fluorescence intensity was read from the bottom of the plate. 
Fluorescence intensities were converted into mass of particles thanks to a calibration curve 
performed in white DMEM. 
 
TEM on cells 
A549 epithelial cells were seeded in T25-flasks. After 48 h (confluence 80%), cells were rinsed 
with PBS and incubated for 4 h at 37 °C with 5 mL of silica or silica-Curosurf® solutions 
(concentration of 1 g L-1 in white DMEM). Cells were washed with PBS and fixed with a 
glutaraldehyde - PFA buffer (1% - 2.5% respectively in PBS) for 1 h at room temperature. Fixed 
cells were further washed with PBS, scratched and centrifuged. The pellets were then postfixed 
during 1 h in a 1% osmium tetroxide solution reduced by a 1.5% potassium ferrocyanide 
solution. After several washes, the samples were dehydrated by addition of ethanol – propylene 
oxide mixtures and wrapped up in epoxy resin. 70 nm-thick sections were cut with an 
ultramicrotome (LEICA, Ultracut UC6) and picked up on copper/formvar carbon grids. They 
were then stained for 7 min with 4% uranyl acetate and for 7 min with 0.2% lead citrate. 
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